A detailed history of Gradient Capital Advisors, LLC transactions in Immuno Precise Antibodies Ltd. stock. As of the latest transaction made, Gradient Capital Advisors, LLC holds 26,808 shares of IPA stock, worth $12,599. This represents 0.01% of its overall portfolio holdings.

Number of Shares
26,808
Previous 26,808 -0.0%
Holding current value
$12,599
Previous $27,000 37.04%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 04, 2022

BUY
$3.77 - $6.39 $25,666 - $43,503
6,808 Added 34.04%
26,808 $107,000
Q4 2021

Jan 31, 2022

SELL
$5.06 - $6.69 $8,693 - $11,493
-1,718 Reduced 7.91%
20,000 $107,000
Q4 2020

Jan 20, 2021

BUY
$6.15 - $18.7 $133,565 - $406,126
21,718 New
21,718 $325,000

Others Institutions Holding IPA

About ImmunoPrecise Antibodies Ltd.


  • Ticker IPA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,836,700
  • Market Cap $11.7M
  • Description
  • ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth ...
More about IPA
Track This Portfolio

Track Gradient Capital Advisors, LLC Portfolio

Follow Gradient Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gradient Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gradient Capital Advisors, LLC with notifications on news.